News

Gilead should know whether its new Sovaldi-based combination therapy for hepatitis C is approvable for the US market within six months, after regulators assigned a priority review to its marketing application.

Roche and the Department of Health have formed a ground-breaking pact to assess whether a veteran arthritis biologic can be repositioned as an effective treatment for pulmonary arterial hypertension.

Public Health England has launched a new smartphone app to help raise awareness of the amount of sugar in food and drink, under a bid to reign in rising tides of obesity and diabetes in the country.

Novel drug approvals in the US have soared to a 19-year high, as the industry continued to hone its R&D focus on treatments for orphan diseases and personalised medicine.

Merck, Pfizer and Syndax have formed a clinical trials pact to evaluate a combination of their cancer drugs in patients with heavily pre-treated, recurrent ovarian cancer. 

The National Health Service has been told to prepare for industrial action by junior doctors next week after contract negotiations between the British Medical Association and the government fell apart.

In a UK first, regulators have issued a licence for an electronic cigarette, thereby classing it a medicine and paving the way for its prescription on the National Health Service.

Shire is reportedly in advanced talks to acquire Baxter’s biopharma spin-off Baxalta and may announce a deal this week.

US regulators recently approved AstraZeneca’ gout therapy Zurampic, offering patients a new approach to treating the condition.

The National Institute for Health and Care Excellence has changed its position on the use of MSD’s Ezetrol on the National Health Service, reverting back to original guidelines published in 2007.

UK patients with advanced melanoma were among the first in the world to access MSD’s Keytruda last year because of the country’s early access to medicines scheme.

Hospitals are saving millions of pounds through a clampdown on management consultants and agency staff, according the Department of Health.

Balancing the books, reducing waiting times and new plans for a sustainable general practice are among nine ‘must-do’ targets set out in NHS guidance for the next six years.

Entrants have only one week left to submit their essay for the International Clinical Researcher of the Year 2016 competition

The world’s largest public-private partnership in life sciences, the Innovative Medicines Initiative (IMI), has launched two new ‘calls for proposals’, offering stakeholders from a variety of sectors the opportunity to take part in scientifically excellent, patient-centric research.